Market sizing and technology mapping for a novel MedTech platform

Transdermjet is an Austrian medical technology company developing a novel drug delivery platform, targeting improved patient outcomes across therapeutic areas currently served by conventional administration routes.

As an early-stage technology company, Transdermjet needed a rigorous, data-driven view of the addressable market for its platform - including therapeutic area prioritization, competing delivery technologies, and the broader innovation landscape. Critical for product strategy and investor engagement.

Delphidata conducted a combined market and technology mapping engagement. We sized and segmented relevant therapeutic markets, assessed competing delivery technologies across maturity levels, profiled active players in the adjacent technology landscape, and evaluated strategic entry angles.

A structured market and technology intelligence package - grounding commercial strategy and providing defensible, externally-sourced analysis for strategic planning and investor materials. The work continues to serve as a reference framework as the platform advances toward commercialization.